Drug Chatter -- Tracking biopharma stock chatter

Profile for Halozyme Therapeutics, Inc. (HALO)

« Back to company index

HALO Chatter Timeline

Stock Ticker for HALO

Most Active Tweeters for HALO

UserTweets
@fezziwig2008 59
@WatchlistN 6
@ThisLincolnian 6
@dailypoliticaln 6
@registrarjourn 6

Recent Tweets for HALO

CI4CC @CI4CC
RT @fezziwig2008: Once again the Only Positive phase 2 Stage 4 #PancreaticCancer Data @ #ASCO18 is given no value- $HALO being priced on En…
May 25th 2018, 10:05pm
CI4CC @CI4CC
RT @fezziwig2008: @abbvie "All" Cancer? - you will have to buy $HALO in order to effectively target High Hyaluronan Solid Cancer, as your I…
May 25th 2018, 9:05pm
fezziwig2008 @fezziwig2008
@abbvie "All" Cancer? - you will have to buy $HALO in order to effectively target High Hyaluronan Solid Cancer, as… https://t.co/uRebp85shx
May 25th 2018, 7:05pm
fezziwig2008 @fezziwig2008
@W_Park_MD Please read up on $HALO's mechanism of action in this indication and related high Hyaluronan cancers. Pl… https://t.co/ncse89A92i
May 25th 2018, 6:05pm
fezziwig2008 @fezziwig2008
RT @fezziwig2008: $HALO beats PARP, Ibrutinib, CAR-T, anti PD-1, anti PD-L1, Folfirinox, standard of care for Stage 4 #Pancreatic Cancer wi…
May 25th 2018, 4:05pm
fezziwig2008 @fezziwig2008
$NVS Cosentyx for Ankylosing Spondylitis weekly subcutaneous injections become monthly with $HALO Enhanze - then… https://t.co/TQtOv57u8K
May 25th 2018, 4:05pm
fezziwig2008 @fezziwig2008
RT @fezziwig2008: "Will $HALO Grow 171.5% This Year? Analysts Think So." https://t.co/XhnJd1l6uK
May 25th 2018, 3:05pm
fezziwig2008 @fezziwig2008
Next $HALO Enhanze Catalyst - maybe announced at $GS Conference https://t.co/NJQtIMNOxF
May 25th 2018, 2:05pm
fezziwig2008 @fezziwig2008
RT @fezziwig2008: "Hyaluronidase Rx sensitized Breast CAFs to lapatinib (Tykerb), thereby removing the protective niche" $GSK $HALO https:/…
May 25th 2018, 1:05pm
Wattwurm73 @Wattwurm73
$HALO 2130 lots Jun18 20 Calls have changed hands
May 25th 2018, 1:05pm
fezziwig2008 @fezziwig2008
$HALO beats PARP, Ibrutinib, CAR-T, anti PD-1, anti PD-L1, Folfirinox, standard of care for Stage 4 #Pancreatic Can… https://t.co/1eNg9x9KNB
May 25th 2018, 1:05pm
fezziwig2008 @fezziwig2008
"Will $HALO Grow 171.5% This Year? Analysts Think So." https://t.co/XhnJd1l6uK
May 25th 2018, 8:05am
TheMarketsDaily @TheMarketsDaily
Halozyme Therapeutics, Inc. $HALO Receives Average Recommendation of “Hold” from Brokerages https://t.co/Ym9vzkt59j
May 24th 2018, 5:05pm
lritchie25 @lritchie25
RT @popastock: $HALO EOD 2 blocks total 288,429. shares off the ask =$5,295,556.44 lunch money? hmm https://t.co/kTjYBxQ52M
May 24th 2018, 5:05pm
popastock @popastock
RT @fezziwig2008: $HALO Apparently 2 Fund Managers agreed that the Valuation of Uniquely Positive #PancreaticCancer Data @ #ASCO18 at $0 is…
May 24th 2018, 4:05pm
fezziwig2008 @fezziwig2008
$HALO Apparently 2 Fund Managers agreed that the Valuation of Uniquely Positive #PancreaticCancer Data @ #ASCO18 at… https://t.co/UcD67YorCF
May 24th 2018, 4:05pm
popastock @popastock
$HALO EOD 2 blocks total 288,429. shares off the ask =$5,295,556.44 lunch money? hmm https://t.co/kTjYBxQ52M
May 24th 2018, 4:05pm
fezziwig2008 @fezziwig2008
@dannydyn1 THe same could have been said for $PCYC pre pivotal data. $HALO
May 24th 2018, 3:05pm
dannydyn1 @dannydyn1
@fezziwig2008 It may be just me, but it seems the investment community is totally oblivious to $HALO's existence.
May 24th 2018, 3:05pm
fezziwig2008 @fezziwig2008
Once again the Only Positive phase 2 Stage 4 #PancreaticCancer Data @ #ASCO18 is given no value- $HALO being priced… https://t.co/QLQ5pvlYyK
May 24th 2018, 2:05pm
fezziwig2008 @fezziwig2008
New Pulmonary data shows $HALO is targeting "a major regulator of Lung innate immunity" significant in NSCLC immuno… https://t.co/ivTu91FHqm
May 24th 2018, 2:05pm
fezziwig2008 @fezziwig2008
RT @fezziwig2008: $DB Peters feels $HALO P3 Hyaluronan Hypothesis will be proven-"we expect increased focus on the PEGPH20 program where we…
May 24th 2018, 1:05pm
ThisLincolnian @ThisLincolnian
-$0.23 Earnings Per Share Expected for Halozyme Therapeutics, Inc. $HALO This Quarter https://t.co/2YbLze5xF9
May 23rd 2018, 10:05pm
TickerReport @TickerReport
Halozyme Therapeutics, Inc. $HALO Expected to Post Earnings of -$0.23 Per Share https://t.co/ojdGg26nqA
May 23rd 2018, 10:05pm
dailypoliticaln @dailypoliticaln
Halozyme Therapeutics, Inc. $HALO Expected to Post Quarterly Sales of $30.90 Million https://t.co/H6qrnCLir8
May 23rd 2018, 10:05pm
registrarjourn @registrarjourn
Zacks: Brokerages Anticipate Halozyme Therapeutics, Inc. $HALO Will Post Quarterly Sales of $30.90 Million https://t.co/wRzPr1y4So
May 23rd 2018, 10:05pm
OlympiaReport @OlympiaReport
Contrasting Halozyme Therapeutics $HALO & Genocea Biosciences $GNCA https://t.co/UWKUXD8MfS
May 23rd 2018, 1:05pm
bigtigerjim @bigtigerjim
RT @fezziwig2008: Note to $HALO Analysts- this Just Published Peer Reviewed Research from Minnesota and London, Ontario demonstrates PegpH…
May 23rd 2018, 12:05pm
fezziwig2008 @fezziwig2008
Note to $HALO Analysts- this Just Published Peer Reviewed Research from Minnesota and London, Ontario demonstrates… https://t.co/UUK3ymMFaJ
May 23rd 2018, 11:05am
bigtigerjim @bigtigerjim
RT @fezziwig2008: $HALO reduces Hyaluronan content in solid tumors- reducing tumor cell migration & invasion-adding to Progression Free & O…
May 23rd 2018, 9:05am
fezziwig2008 @fezziwig2008
$HALO reduces Hyaluronan content in solid tumors- reducing tumor cell migration & invasion-adding to Progression Fr… https://t.co/ANkSU1zSTf
May 23rd 2018, 9:05am
fezziwig2008 @fezziwig2008
$HALO @JMP 6/20 Current JMP Price Target $21 https://t.co/htOOCqGbFq
May 23rd 2018, 8:05am
mtpoulsen @mtpoulsen
RT @fezziwig2008: The blockbuster potential of PegPh20 to $HALO is not just in metastatic #PancreaticCancer- This is the High Hyaluronan Pr…
May 22nd 2018, 4:05pm
fezziwig2008 @fezziwig2008
The blockbuster potential of PegPh20 to $HALO is not just in metastatic #PancreaticCancer- This is the High Hyaluro… https://t.co/oETQIYHFuR
May 22nd 2018, 3:05pm
fezziwig2008 @fezziwig2008
$HALO dropping on fresh #ASCO 18 data- granted in a small targeted study -showing PegpH20 takes the lesser standard… https://t.co/fqHZaeYNk3
May 22nd 2018, 10:05am
fezziwig2008 @fezziwig2008
Both patients & $MRK have unmet need in second line Gastric Cancer - $HALO PegpH20 is uniquely targeted to meet it… https://t.co/WBkHdxnvFP
May 22nd 2018, 7:05am
registrarjourn @registrarjourn
BidaskClub Lowers Halozyme Therapeutics $HALO to Buy https://t.co/lino2GK3jc
May 22nd 2018, 6:05am
OlympiaReport @OlympiaReport
BidaskClub Lowers Halozyme Therapeutics $HALO to Buy https://t.co/nBEg2zxtDB
May 22nd 2018, 4:05am
WarrenofWallSt @WarrenofWallSt
Is it too late for potential investors in #HalozymeTherapeutics $HALO? Mr Market has already priced in the -265.8%… https://t.co/dKrOmR9cEt
May 22nd 2018, 1:05am
ConsumerFeed @ConsumerFeed
Zacks: Analysts Anticipate Halozyme Therapeutics, Inc. $HALO Will Post Quarterly Sales of $30.90 Million https://t.co/zsi5jrs290
May 21st 2018, 2:05pm
WatchlistN @WatchlistN
Zacks: Brokerages Anticipate Halozyme Therapeutics, Inc. $HALO to Announce -$0.23 Earnings Per Share https://t.co/iuuLEYBRy6
May 21st 2018, 2:05pm
registrarjourn @registrarjourn
Zacks: Brokerages Expect Halozyme Therapeutics, Inc. $HALO to Announce -$0.23 Earnings Per Share https://t.co/zYSkTw74tV
May 21st 2018, 2:05pm
mtpoulsen @mtpoulsen
RT @fezziwig2008: $HALO w surrogate PFS endpoint 0.59 HR & current FDA =2019 Approval https://t.co/dAcET2wgEG
May 21st 2018, 12:05pm
fezziwig2008 @fezziwig2008
$HALO w surrogate PFS endpoint 0.59 HR & current FDA =2019 Approval https://t.co/dAcET2wgEG
May 21st 2018, 12:05pm
fezziwig2008 @fezziwig2008
$HALO 202 achieved a 0.51 Hazard Ratio for PFS/ P3 PFS primary endpoint will be met with only a 0.59 HR - a slight… https://t.co/YzP8MQD9Lz
May 21st 2018, 11:05am
fezziwig2008 @fezziwig2008
RT @fezziwig2008: Margaret Tempero, MD. Director, UCSF Pancreas Center; Leader, Pancreas Cancer Program https://t.co/7q9VhBMRGA $HALO 202 B…
May 21st 2018, 11:05am
lritchie25 @lritchie25
RT @fezziwig2008: $HALO New Blog on P3 Slowed Event Rate on @SeekingAlpha https://t.co/XmWm0cG7Az
May 21st 2018, 9:05am
dailypoliticaln @dailypoliticaln
Halozyme Therapeutics $HALO Downgraded by ValuEngine to “Hold” https://t.co/F6D3t4LjEo
May 21st 2018, 6:05am
TickerReport @TickerReport
Halozyme Therapeutics $HALO Downgraded by ValuEngine to “Hold” https://t.co/nnNmQcZPC1
May 21st 2018, 6:05am
ledgerzette @ledgerzette
Halozyme Therapeutics $HALO Downgraded by ValuEngine to “Hold” https://t.co/JyVBQfKgQ2
May 21st 2018, 6:05am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.